Orion Biotech Opportunities Corp (ORIA)
$10.23
$0.00 (0.00%)As on 17-May-2023 09:30EDT
Market cap
$256 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
29.2
P/B Ratio
1.3
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$7 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
--
-
Book Value
$39
-
EPS
$3.7
-
Face value
--
-
Shares outstanding
20,000,000
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
| 1.8 | -0.1 | 0.8 | 4.5 | -- | -- | -- |
|
BSE Sensex*
| -10.7 | -3.7 | 1.8 | -6.4 | 4.5 | 5.3 | 10.1 |
|
Company
|
2022
|
|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
| 3.9 |
|
BSE Sensex
| 4.4 |
|
BSE Sensex
| 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
10.2 | 255.8 | 0.0 | 18.4 | -- | 9.7 | 29.2 | 1.3 |
| 10.1 | 295.9 | 0.0 | -7.4 | -- | -- | -- | 4.2 |
Shareholding Pattern
View DetailsAbout Orion Biotech Opportunities Corp (ORIA)
Orion Biotech Opportunities Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company... intends to acquire businesses in the biotechnology and life sciences sectors. Orion Biotech Opportunities Corp. was incorporated in 2021 and is based in New York, New York. Read more
-
CEO & Director
Mr. Zuie-Chin Huang M.B.A.
-
CEO & Director
Mr. Zuie-Chin Huang M.B.A.
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Orion Biotech Opportunities Corp (ORIA)
What is the current share price of Orion Biotech Opportunities Corp (ORIA) Today?
The share price of Orion Biotech Opportunities Corp (ORIA) is $10.23 (NASDAQ) as of 17-May-2023 09:30 EDT. Orion Biotech Opportunities Corp (ORIA) has given a return of 4.49% in the last 1 years.
What is the current PB & PE ratio of Orion Biotech Opportunities Corp (ORIA)?
The P/E ratio of Orion Biotech Opportunities Corp (ORIA) is 29.23 times as on 17-May-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
2.73 |
0.26 |
2021 |
-58.92 |
0.26 |
2022 |
2.73 |
0.26 |
2021 |
-58.92 |
0.26 |
What is the 52 Week High and Low of Orion Biotech Opportunities Corp (ORIA)?
The 52-week high and low of Orion Biotech Opportunities Corp (ORIA) are Rs -- and Rs -- as of 08-Sep-2026.
What is the market cap of Orion Biotech Opportunities Corp (ORIA)?
Orion Biotech Opportunities Corp (ORIA) has a market capitalisation of $ 256 Mln as on 17-May-2023. As per SEBI classification, it is a company.
Should I invest in Orion Biotech Opportunities Corp (ORIA)?
Before investing in Orion Biotech Opportunities Corp (ORIA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.